Year |
Citation |
Score |
2023 |
Patel KK, Brogden NK. Impact of Formulation and Microneedle Length on Transdermal Metronidazole Permeation through Microneedle-Treated Skin. Pharmaceutical Research. PMID 38133717 DOI: 10.1007/s11095-023-03640-8 |
0.433 |
|
2023 |
Smith R, Brogden N, Fiegel J. Sprayable ciprofloxacin-loaded poloxamer hydrogels for wound infection treatment. Journal of Drug Delivery Science and Technology. 89. PMID 37928051 DOI: 10.1016/j.jddst.2023.105000 |
0.441 |
|
2023 |
Cai Q, Azarpanah A, Bhatt JA, Wei H, Carr J, Morris KR, Strasinger C, Brogden NK. Examination of the Rate and Extent of Drug Released from Commercial Topical Delivery Systems During Wear: An Example with Lidocaine Topical Systems. Pharmaceutical Research. PMID 37848751 DOI: 10.1007/s11095-023-03617-7 |
0.781 |
|
2023 |
Tobin KV, Brogden NK. Thermosensitive biomaterial gels with chemical permeation enhancers for enhanced microneedle delivery of naltrexone for managing opioid and alcohol dependency. Biomaterials Science. 11: 5846-5858. PMID 37455601 DOI: 10.1039/d3bm00972f |
0.413 |
|
2023 |
Smith R, Ruben C, Pradhan O, Brogden N, Fiegel J. Spray Coverage Analysis of Topical Sprays Formed by Cold Thermoreversible Hydrogels. Drug Development and Industrial Pharmacy. 1-41. PMID 37354008 DOI: 10.1080/03639045.2023.2229919 |
0.42 |
|
2022 |
Russo J, Fiegel J, Brogden NK. Effect of Salt Form on Gelation and Drug Delivery Properties of Diclofenac-Loaded Poloxamer Gels for Delivery to Impaired Skin. Pharmaceutical Research. PMID 36002613 DOI: 10.1007/s11095-022-03356-1 |
0.537 |
|
2021 |
Ogunjimi AT, Lawson C, Carr J, Patel KK, Ferguson N, Brogden NK. Micropore Closure Rates following Microneedle Application at Various Anatomical Sites in Healthy Human Subjects. Skin Pharmacology and Physiology. 1-15. PMID 33910205 DOI: 10.1159/000515454 |
0.458 |
|
2021 |
Tobin KV, Fiegel J, Brogden NK. Thermosensitive Gels Used to Improve Microneedle-Assisted Transdermal Delivery of Naltrexone. Polymers. 13. PMID 33803552 DOI: 10.3390/polym13060933 |
0.473 |
|
2020 |
Russo J, Fiegel J, Brogden NK. Rheological and Drug Delivery Characteristics of Poloxamer-Based Diclofenac Sodium Formulations for Chronic Wound Site Analgesia. Pharmaceutics. 12. PMID 33333773 DOI: 10.3390/pharmaceutics12121214 |
0.454 |
|
2020 |
Ogunjimi AT, Carr J, Lawson C, Ferguson N, Brogden NK. Micropore closure time is longer following microneedle application to skin of color. Scientific Reports. 10: 18963. PMID 33144596 DOI: 10.1038/s41598-020-75246-8 |
0.36 |
|
2020 |
Ogunjimi AT, Fiegel J, Brogden NK. Design and Characterization of Spray-Dried Chitosan-Naltrexone Microspheres for Microneedle-Assisted Transdermal Delivery. Pharmaceutics. 12. PMID 32485999 DOI: 10.3390/Pharmaceutics12060496 |
0.633 |
|
2020 |
Swaminathan SK, Strasinger C, Kelchen M, Carr J, Ye W, Wokovich A, Ghosh P, Rajagopal S, Ueda K, Fisher J, Kandimalla KK, Brogden NK. Determination of Rate and Extent of Scopolamine Release from Transderm Scōp® Transdermal Drug Delivery Systems in Healthy Human Adults. Aaps Pharmscitech. 21: 117. PMID 32300962 DOI: 10.1208/S12249-020-01658-4 |
0.756 |
|
2020 |
Smith R, Russo J, Fiegel J, Brogden N. Antibiotic Delivery Strategies to Treat Skin Infections When Innate Antimicrobial Defense Fails. Antibiotics (Basel, Switzerland). 9. PMID 32024064 DOI: 10.3390/Antibiotics9020056 |
0.487 |
|
2019 |
Gao X, Brogden NK. Development of hydrogels for microneedle-assisted transdermal delivery of naloxone for opioid induced pruritus. Journal of Pharmaceutical Sciences. PMID 31476312 DOI: 10.1016/J.Xphs.2019.08.025 |
0.524 |
|
2018 |
Kelchen MN, Brogden NK. Effect of dosing regimen and microneedle pretreatment on in vitro skin retention of topically applied beta-blockers. Biomedical Microdevices. 20: 100. PMID 30523423 DOI: 10.1007/S10544-018-0348-7 |
0.571 |
|
2018 |
Kelchen MN, Brogden NK. In Vitro Skin Retention and Drug Permeation through Intact and Microneedle Pretreated Skin after Application of Propranolol Loaded Microemulsions. Pharmaceutical Research. 35: 228. PMID 30302631 DOI: 10.1007/S11095-018-2495-1 |
0.593 |
|
2018 |
Kelchen MN, Menon G, Ten Eyck P, Prettypaul D, Brogden NK. A Pilot Study to Evaluate the Effects of Topically Applied Cosmetic Creams on Epidermal Responses. Skin Pharmacology and Physiology. 31: 269-282. PMID 30110695 DOI: 10.1159/000490531 |
0.356 |
|
2017 |
Santos PL, Brito RG, Quintans JS, Araújo AA, Menezes IR, Brogden NK, Quintans-Júnior LJ. Cyclodextrins as Encapsulation Agents to Improve the Anti-inflammatory Drugs Profile: a Systematic Review and Meta-Analysis. Current Pharmaceutical Design. PMID 28128055 DOI: 10.2174/1381612823666170126121926 |
0.452 |
|
2016 |
Kelchen MN, Siefers KJ, Converse CC, Farley MJ, Holdren GO, Brogden NK. Micropore closure kinetics are delayed following microneedle insertion in elderly subjects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 225: 294-300. PMID 26829102 DOI: 10.1016/J.Jconrel.2016.01.051 |
0.589 |
|
2015 |
Kinn PM, Holdren GO, Westermeyer BA, Abuissa M, Fischer CL, Fairley JA, Brogden KA, Brogden NK. Age-dependent variation in cytokines, chemokines, and biologic analytes rinsed from the surface of healthy human skin. Scientific Reports. 5: 10472. PMID 26035055 DOI: 10.1038/Srep10472 |
0.429 |
|
2014 |
Holdren GO, Rosenthal DJ, Yang J, Bates AM, Fischer CL, Zhang Y, Brogden NK, Brogden KA. Antimicrobial Activity of Chemokine CXCL10 for Dermal and Oral Microorganisms. Antibiotics (Basel, Switzerland). 3: 527-539. PMID 25859394 DOI: 10.3390/Antibiotics3040527 |
0.322 |
|
2014 |
Kelchen MN, Holdren GO, Farley MJ, Zimmerman MB, Fairley JA, Brogden NK. Optimization of impedance spectroscopy techniques for measuring cutaneous micropore formation after microneedle treatment in an elderly population. Pharmaceutical Research. 31: 3478-86. PMID 24947437 DOI: 10.1007/S11095-014-1435-Y |
0.369 |
|
2014 |
Ghosh P, Brogden NK, Stinchcomb AL. Fluvastatin as a micropore lifetime enhancer for sustained delivery across microneedle-treated skin. Journal of Pharmaceutical Sciences. 103: 652-60. PMID 24395718 DOI: 10.1002/Jps.23844 |
0.839 |
|
2013 |
Milewski M, Paudel KS, Brogden NK, Ghosh P, Banks SL, Hammell DC, Stinchcomb AL. Microneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation. Molecular Pharmaceutics. 10: 3745-57. PMID 24053426 DOI: 10.1021/Mp400227E |
0.736 |
|
2013 |
Brogden NK, Banks SL, Crofford LJ, Stinchcomb AL. Diclofenac enables unprecedented week-long microneedle-enhanced delivery of a skin impermeable medication in humans. Pharmaceutical Research. 30: 1947-55. PMID 23761054 DOI: 10.1007/S11095-013-1036-1 |
0.816 |
|
2013 |
Ghosh P, Brogden NK, Stinchcomb AL. Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery. Molecular Pharmaceutics. 10: 2331-9. PMID 23590208 DOI: 10.1021/Mp3007083 |
0.794 |
|
2013 |
Brogden NK, Ghosh P, Hardi L, Crofford LJ, Stinchcomb AL. Development of in vivo impedance spectroscopy techniques for measurement of micropore formation following microneedle insertion. Journal of Pharmaceutical Sciences. 102: 1948-56. PMID 23589356 DOI: 10.1002/Jps.23544 |
0.779 |
|
2012 |
Brogden NK, Milewski M, Ghosh P, Hardi L, Crofford LJ, Stinchcomb AL. Diclofenac delays micropore closure following microneedle treatment in human subjects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 163: 220-9. PMID 22929967 DOI: 10.1016/J.Jconrel.2012.08.015 |
0.815 |
|
2012 |
Brogden NK, Mehalick L, Fischer CL, Wertz PW, Brogden KA. The emerging role of peptides and lipids as antimicrobial epidermal barriers and modulators of local inflammation. Skin Pharmacology and Physiology. 25: 167-81. PMID 22538862 DOI: 10.1159/000337927 |
0.305 |
|
2011 |
Banks SL, Paudel KS, Brogden NK, Loftin CD, Stinchcomb AL. Diclofenac enables prolonged delivery of naltrexone through microneedle-treated skin. Pharmaceutical Research. 28: 1211-9. PMID 21301935 DOI: 10.1007/S11095-011-0372-2 |
0.803 |
|
2010 |
Paudel KS, Milewski M, Swadley CL, Brogden NK, Ghosh P, Stinchcomb AL. Challenges and opportunities in dermal/transdermal delivery. Therapeutic Delivery. 1: 109-31. PMID 21132122 DOI: 10.4155/Tde.10.16 |
0.683 |
|
2010 |
Milewski M, Brogden NK, Stinchcomb AL. Current aspects of formulation efforts and pore lifetime related to microneedle treatment of skin. Expert Opinion On Drug Delivery. 7: 617-29. PMID 20205604 DOI: 10.1517/17425241003663228 |
0.836 |
|
2010 |
Banks SL, Pinninti RR, Gill HS, Paudel KS, Crooks PA, Brogden NK, Prausnitz MR, Stinchcomb AL. Transdermal delivery of naltrexol and skin permeability lifetime after microneedle treatment in hairless guinea pigs Journal of Pharmaceutical Sciences. 99: 3072-3080. PMID 20166200 DOI: 10.1002/Jps.22083 |
0.81 |
|
Show low-probability matches. |